PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients

Go back to PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 219.07 +3.57 (1.66%)
Previous Close $215.50    52 Week High $333.65 
Open $216.14    52 Week Low $223.02 
Day High $221.92    P/E 28.05 
Day Low $214.59    EPS $7.81 
Volume 928,562